Previous Close | 0.1500 |
Open | 0.1500 |
Bid | 0.0000 |
Ask | 0.2000 |
Strike | 12.00 |
Expire Date | 2024-11-15 |
Day's Range | 0.1500 - 0.1500 |
Contract Range | N/A |
Volume | |
Open Interest | 26 |
Innovative Cancer Treatment Gains Regulatory Approval
Optune Lua received US Food and Drug Administration (FDA) approval based on data from the pivotal LUNAR trial, which demonstrated significant median overall survival (OS) improvement.